GSK plc has today announced that Wendy Becker will become a non-executive director of the company. Becker will become a member of the company’s remuneration and audit & risk committees.
After GSK’s 2024 AGM, she will succeed Urs Rohner as chair of the remuneration committee when he steps down on completion of his nine years’ service to the board.
Becker is currently chair of Logitech International, and chairs Sony Group’s compensation committee. Her executive management experience was gained through senior roles at McKinsey & Company, TalkTalk, Vodafone and as CEO at Jack Wills.
Within the life sciences sector, Becker is chair of the remuneration committee of Oxford Nanopore Technologies. She is a member of the governing bodies of the University of Oxford and related subsidiaries.
Commenting on Becker’s appointment, Sir Jonathan Symonds, chair of GSK said: “I am delighted to welcome Wendy to GSK. Wendy is a highly experienced, non-executive director, and has held significant leadership positions in a wide range of global businesses, including several in the technology and life sciences sectors. I’m sure she will make a significant contribution to the board and we look forward to her joining in October.”